title: Role of MIBI breast scintigraphy in evaluation of palpable breast lesions.
abstract: The sensitivity and specificity of MIBI breast scintigraphy, conventional mammography and ultrasound in differentiating malignant and benign palpable breast lesions was compared in 48 women. MIBI breast scintigraphy had a sensitivity of 97% a specificity of 69%, a positive predictive value of 87.5% and a negative predictive value of 91.7%. Ultrasound and mammography had comparable results with accuracy rates of approximately 93%. We conclude that MIBI breast scintigraphy may have a complementary role in the evaluation of palpable breast lesions, but is not specific enough to replace current imaging modalities.
authors.affiliation: Department of Diagnostic Radiology, Prince of Wales Hospital, Ngan Shing Street, Shatin, Hong Kong.
authors.forename: W W
authors.initials: WW
authors.lastname: Lam
authors.forename: W T
authors.initials: WT
authors.lastname: Yang
authors.forename: Y L
authors.initials: YL
authors.lastname: Chan
authors.forename: I E
authors.initials: IE
authors.lastname: Stewart
authors.forename: W
authors.initials: W
authors.lastname: King
authors.forename: C
authors.initials: C
authors.lastname: Metreweli
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000000981:diagnostic imaging*; D002277:Carcinoma / Q000000981:diagnostic imaging*; D003287:Contrast Media; D005260:Female; D018226:Fibroadenoma / Q000000981:diagnostic imaging*; D006801:Humans; D008327:Mammography; D008875:Middle Aged; D003557:Phyllodes Tumor / Q000000981:diagnostic imaging*; D011446:Prospective Studies; D011877:Radionuclide Imaging; D012680:Sensitivity and Specificity; D017256:Technetium Tc 99m Sestamibi; D016217:Ultrasonography, Mammary
chemical_list: D003287:Contrast Media; D017256:Technetium Tc 99m Sestamibi